|Alterola Biotech Inc -- USA Stock|| |
USD 1.52 0.00 0.00%
Deputy CEO of Altarea France
Mr. Albert Malaquin is Deputy Chief Executive Officer of Altarea France at Altarea SCA. He is also a Member of the Company Strategy Committee.
The company has return on total asset (ROA)
of (133.34) %
which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech Inc has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
|Found 1 records|
|Ben Beurden||Royal Dutch Shell plc|
Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech Inc (ALTA) is traded on OTC Market in USA. It is located in Alterola Biotech, Inc.Walnut, CA and employs 1 people.